Citadel Advisors’s BioTelemetry, Inc. BEAT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-34,200
| Closed | -$2.46M | – | 14108 |
|
|
2020
Q4 | $2.46M | Buy |
34,200
+26,400
| +338% | +$1.38M | ﹤0.01% | 4921 |
|
|
2020
Q3 | $356K | Buy |
+7,800
| New | +$326K | ﹤0.01% | 7858 |
|
|
2020
Q2 | – | Sell |
-18,900
| Closed | -$728K | – | 10964 |
|
|
2020
Q1 | $728K | Buy |
18,900
+8,800
| +87% | +$405K | ﹤0.01% | 5868 |
|
|
2019
Q4 | $468K | Sell |
10,100
-200
| -2% | -$8.66K | ﹤0.01% | 6927 |
|
|
2019
Q3 | $420K | Sell |
10,300
-15,100
| -59% | -$652K | ﹤0.01% | 7050 |
|
|
2019
Q2 | $1.22M | Sell |
25,400
-43,000
| -63% | -$2.26M | ﹤0.01% | 5373 |
|
|
2019
Q1 | $4.28M | Buy |
68,400
+26,500
| +63% | +$1.82M | ﹤0.01% | 3224 |
|
|
2018
Q4 | $2.5M | Sell |
41,900
-6,600
| -14% | -$396K | ﹤0.01% | 3803 |
|
|
2018
Q3 | $3.13M | Buy |
48,500
+33,200
| +217% | +$1.85M | ﹤0.01% | 3666 |
|
|
2018
Q2 | $689K | Sell |
15,300
-2,500
| -14% | -$99.7K | ﹤0.01% | 5852 |
|
|
2018
Q1 | $553K | Buy |
17,800
+1,400
| +9% | +$46K | ﹤0.01% | 5726 |
|
|
2017
Q4 | $490K | Sell |
16,400
-2,000
| -11% | -$57.9K | ﹤0.01% | 5685 |
|
|
2017
Q3 | $607K | Buy |
18,400
+8,200
| +80% | +$284K | ﹤0.01% | 5033 |
|
|
2017
Q2 | $341K | Sell |
10,200
-31,400
| -75% | -$937K | ﹤0.01% | 5706 |
|
|
2017
Q1 | $1.2M | Buy |
41,600
+30,000
| +259% | +$743K | ﹤0.01% | 3746 |
|
|
2016
Q4 | $259K | Sell |
11,600
-6,000
| -34% | -$117K | ﹤0.01% | 5885 |
|
|
2016
Q3 | $327K | Sell |
17,600
-14,800
| -46% | -$279K | ﹤0.01% | 5533 |
|
|
2016
Q2 | $528K | Buy |
+32,400
| New | +$477K | ﹤0.01% | 4405 |
|
|
2016
Q1 | – | Sell |
-6,600
| Closed | -$77K | – | 9190 |
|
|
2015
Q4 | $77K | Sell |
6,600
-15,800
| -71% | -$200K | ﹤0.01% | 6951 |
|
|
2015
Q3 | $274K | Buy |
22,400
+13,200
| +143% | +$168K | ﹤0.01% | 5708 |
|
|
2015
Q2 | $87K | Sell |
9,200
-300
| -3% | -$2.78K | ﹤0.01% | 7227 |
|
|
2015
Q1 | $84K | Buy |
9,500
+6,400
| +206% | +$64.7K | ﹤0.01% | 6991 |
|
|
2014
Q4 | $31K | Sell |
3,100
-2,100
| -40% | -$18K | ﹤0.01% | 7544 |
|
|
2014
Q3 | $35K | Buy |
5,200
+500
| +11% | +$3.51K | ﹤0.01% | 7129 |
|
|
2014
Q2 | $34K | Sell |
4,700
-2,900
| -38% | -$23.1K | ﹤0.01% | 7022 |
|
|
2014
Q1 | $77K | Sell |
7,600
-9,500
| -56% | -$87.4K | ﹤0.01% | 6417 |
|
|
2013
Q4 | $136K | Sell |
17,100
-16,400
| -49% | -$153K | ﹤0.01% | 5367 |
|
|
2013
Q3 | $332K | Buy |
33,500
+11,800
| +54% | +$92.9K | ﹤0.01% | 4242 |
|
|
2013
Q2 | $128K | Buy |
+21,700
| New | +$73K | ﹤0.01% | 5037 |
|
Other funds holding BEAT
Citadel Advisors's BEAT Position: Q1 2021 in Review
Citadel Advisors sold out of BioTelemetry, Inc. (BEAT) in Q1 2021, closing a stake of 25,255 shares — an estimated $1.82M sold.
Citadel Advisors first reported a position in BEAT in Q2 2013 and held it in 29 quarters. The position peaked at $6.07M in Q2 2019. 1 fund tracked by Wall St. Rank holds BEAT as of Q1 2021.
- Citadel Advisors reported no remaining BioTelemetry, Inc. position as of Q1 2021 after selling out during the quarter.
- Citadel Advisors sold 25,255 BioTelemetry, Inc. shares in Q1 2021, an estimated $1.82M.
- Citadel Advisors first reported a position in BioTelemetry, Inc. in Q2 2013 and held it in 29 quarters.
- Citadel Advisors's BioTelemetry, Inc. position peaked at $6.07M in Q2 2019.
- 1 fund tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2021.
Based on Citadel Advisors's 13F filing for Q1 2021, filed 17 May 2021.